Literature DB >> 12705862

Another tie that binds the MTA family to breast cancer.

Rakesh Kumar1.   

Abstract

In this issue of Cell, demonstrate that MTA3 is an estrogen-dependent component of the NuRD complex and identify the Snail gene as its direct target. ER signaling upregulates MTA3 levels to negatively modulate Snail-mediated repression of E-cadherin. These findings may explain how ER status controls epithelial-to-mesenchymal transition in human breast tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705862     DOI: 10.1016/s0092-8674(03)00274-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

Authors:  Xavier Le Guezennec; Michiel Vermeulen; Arie B Brinkman; Wieteke A M Hoeijmakers; Adrian Cohen; Edwin Lasonder; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

2.  Expression of metastasis-associated protein 3 in human brain glioma related to tumor prognosis.

Authors:  Shouqin Shan; Guangyan Hui; Fanggao Hou; Hua Shi; Guoqing Zhou; Han Yan; Lu Wang; Jinfeng Liu
Journal:  Neurol Sci       Date:  2015-05-23       Impact factor: 3.307

Review 3.  Cancer biology and NuRD: a multifaceted chromatin remodelling complex.

Authors:  Anne Y Lai; Paul A Wade
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

4.  Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.

Authors:  Yukun Cui; Airu Niu; Richard Pestell; Rakesh Kumar; Edward M Curran; Yunde Liu; Suzanne A W Fuqua
Journal:  Mol Endocrinol       Date:  2006-04-27

Review 5.  Role of MTA1 in cancer progression and metastasis.

Authors:  Nirmalya Sen; Bin Gui; Rakesh Kumar
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

6.  Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Authors:  Ines Barone; Lauren Brusco; Guowei Gu; Jennifer Selever; Amanda Beyer; Kyle R Covington; Anna Tsimelzon; Tao Wang; Susan G Hilsenbeck; Gary C Chamness; Sebastiano Andò; Suzanne A W Fuqua
Journal:  J Natl Cancer Inst       Date:  2011-03-29       Impact factor: 13.506

Review 7.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

8.  Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.

Authors:  Xiao-Yong Zhang; Lauren M DeSalle; Jagruti H Patel; Anthony J Capobianco; Duonan Yu; Andrei Thomas-Tikhonenko; Steven B McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

9.  Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway.

Authors:  Hao Zhang; Rajesh R Singh; Amjad H Talukder; Rakesh Kumar
Journal:  Genes Dev       Date:  2006-10-18       Impact factor: 11.361

10.  Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.

Authors:  K Lundgren; B Nordenskjöld; G Landberg
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.